Objectives: to assess the level of depressive symptomatology in a community based group of patients with Parkinson's disease (PD) and their carers and to investigate the patient characteristics that might predict carer distress. Methods: the GDS-15 geriatric depression scale was used to measure self-rated depressive symptoms in a group of 132 subjects with clinically probable PD randomly selected from a community-based disease register. Disease severity was assessed by the Webster scale and cognitive function by the CAMCOG test. Carers of the patients, who in this study were all spouses, were also asked to complete the GDS-15. Results: a total of 64% of our group of patients and 34% of carers scored within the 'depressed' range on the GDS-15. Patients with high levels of depressive symptoms tended to have more severe disease, disease of longer duration and more impaired cognitive function. The GDS score of the carer was best predicted by the GDS score of the patient being cared for. Less than 10% of patients and carers were being treated with antidepressant medication. Conclusions: this community-based study confirms the high level of depressive symptoms in PD suggested by hospital-and clinic-based studies. Depression in patients appears to be related to disease severity and cognitive impairment. An important determinant of carer distress and mood disorder, as reflected by the GDS score, appears to be the level of depression expressed by the patient being cared for. Despite high levels of depressive symptoms in both patients and carers, very few subjects were in receipt of antidepressant drug therapy.
Introduction
The most common neuropsychiatric complication of Parkinson's disease (PD) is depression [1] . Prevalence figures for depression in PD vary widely and, due to methodological differences between studies, are difficult to compare. Studies using standardized criteria for both depression and PD in hospital-based patient populations generally report a prevalence for major depression of around 40% [1] , although much lower figures have also been reported [2] . The prevalence of depression in community-based populations of subjects with PD remains to be established, although two recently published studies have reported figures for depression of 33% [3] and 26% [4] . The prevalence of major affective disorder, as defined by the criteria of fourth edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), may also be lower in the community than in hospital-based studies. Two community-based studies have reported frequencies for major depression based on DSM-IV criteria of around 8% [4] and 3% [5] of subjects.
Because depressive symptoms in PD are so common and potentially reversible by pharmacological and nonpharmacological means, it is important that depression is recognized and treated. Antidepressant drug therapy is effective in treating depression in PD [6] , although the older tricyclic antidepressants are poorly tolerated [7] . The newer antidepressant drugs such as the selective serotonin re-uptake inhibitors have still to be evaluated in PD, although one study has demonstrated the effectiveness of sertraline in this condition [8] . Cognitive therapy is effective in the treatment of depression but has not been evaluated in PD.
The self-report screening instruments available to detect depressive symptomatology would seem suitable for use in community-based studies. The shortened version of the self-administered Geriatric Depression Scale [9] , the GDS-15, has been validated in elderly community dwellers and elderly patients in other settings [10, 11] . A cut-off point of Ն5 on the GDS-15 has a sensitivity around 90% and a specificity of 70% when compared with validated psychiatric diagnosis [10, 12] .
Most patients with PD requiring some care are looked after by relatives, usually a spouse, at home. Little is known about how depression in a patient with PD affects the level of distress experienced by a carer. One study found that distress in carers was best predicted by motor impairment of the patient with PD [13] , although a more recent study, in hospital inpatients, reported that carer distress was correlated strongly with the level of depression, rather than physical disability, in the patient for whom they were caring [14] . The latter study also demonstrated for the first time that carers of subjects with PD showed higher levels of distress and strain than age-matched spouses of subjects in good health [14] . Whether a similar relationship exists between carer distress and patient depression in community samples is unknown.
The detection and active treatment of depression in patients with PD may be important in treating the distress of their carers. In this study we have used the GDS-15 to screen for depressive symptoms in a community-based sample of PD patients and their carers to establish the frequency of depression in these two groups and positive predictors of carer distress.
Methods
A random sample of 132 subjects with clinically probable PD [15] without severe dementia was drawn from a community-based register for parkinsonism that has been established in a geographically defined area of North Wales. Cases of parkinsonism were identified on the basis of receipt from general practitioner of a prescription of anti-parkinsonian medication. All general practices in the study area used computerized prescribing systems and could generate a list of all subjects receiving treatment for PD. Patients ascertained in this way were visited at home and a history was taken and neurological examination performed. The presence or absence of true parkinsonism and the likely type of parkinsonism present was determined by this assessment and the examination of any available medical records. Diagnosis was based on the best currently available diagnostic criteria [15] .
Patients with PD were invited to complete the GDS-15 and the CAMCOG assessment of cognitive function [16] as part of a semi-structured interview in their own homes or institutional setting. Patients who scored <70 on the CAMCOG, indicating severe dementia, were not included in this study. If requested, assistance in completing these assessments was given to those with sensory or motor difficulties. Demographic details and medical histories of the PD patients were also collected at the time of interview. All subjects were screened for depressive symptomatology by use of the GDS-15, using a cut-off value of Ն5 to indicate clinically important depressive symptoms. Formal psychiatric diagnosis was not attempted.
The severity of PD was measured by the Webster rating scale, taking a score of 0-10 as indicating mild disease, 10-20 as moderate disease and 20-30 as advanced disease [17] .
Where a patient had a spouse living with them who was the main carer, the spouse was also invited to complete the GDS-15. Of the 132 subjects selected for this study 79 had a spouse as main carer.
The data were analysed using the SPSS for Windows release 6.0 statistical computer package.
Results
The demographic details of the patients and their disease severity ratings are given in Table 1 . The overall mean score on the GDS-15 for the PD group was 5.6 (range 0-13). A total of 84 (64%) of PD patients had significant depressive symptoms using the GDS-15. No significant differences were observed between PD patients with and without significant depressive symptoms in terms of age, sex, age of onset of PD or previous reported history of depressive illness. Differences were observed between the two groups in relation to disease severity, duration of disease and score on the CAMCOG assessment of cognitive function (P < 0.05 see Table 2 ). Demographic details and GDS-15 scores of carers are shown in Table 3 . There were significantly more women caring for a disabled partner in the depressed PD group (P < 0.05). The mean GDS-15 score for the carers was 3.6. A total of 28 (35%) scored Ն5 on the GDS-15 and 6% were receiving antidepressant medication from their general practitioner. A between-group analysis of carers of depressed and non-depressed PD patients demonstrated significantly more depressive symptomatology in those caring for depressed patients (P < 0.05, see Table 2 ).
The correlation between characteristics of the PD patient being cared for and the carer's GDS-15 score is shown in Table 4 . The only patient variable that correlated strongly with the carer's GDS-15 score was the patient's GDS-15 score. While neither disease severity nor disease duration correlated with the carer's GDS-15 score, there was a trend in the data to suggest that impaired cognitive function in the patient (indicated by a low CAMCOG score) was associated with higher levels of mood disturbance in the carer.
Discussion
This community-based study confirms that PD is associated with high levels of depressive symptomatology, with 64% of the patient group scoring in the 'depressed' range of the GDS-15. The impression gained from patient interviews was that, whereas depressive symptoms were very common in the patient group, the occurrence of major affective disorder was relatively rare. Depression in patients was associated with severity of disease, as measured by the Webster scale, and disease duration-both of which clearly interact. This has been found by most [18] [19] [20] but not all other investigators [21] . It is likely that the relationship between disease severity, disease duration and mood disorder is complex and this study could not address the issue of whether change in disability is more important than absolute disability or whether an increase in disability occurring soon after diagnosis and again in advanced disease is a more powerful predictor of mood in the patient than absolute levels of disability [19] .
We also found that depressive symptoms were common in carers, with over one-third of carers scoring in the depressed range on the GDS-15.
The only patient variable that correlated with the presence of depressive symptoms in the carer was the GDS-15 score. This supports the findings of the only other recent study of depression in carers of patients with PD recruited mainly from hospital sources [14] .
However, there are several points that must be borne in mind when considering our findings. Our conclusions are limited by the method of ascertainment of cases of PD, the use of a self-rating scale to determine depressive symptoms and the cross-sectional design of the study. Our group of subjects with PD was restricted to those medically diagnosed and in receipt of anti-parkinsonian medication. Possibly 50% of symptomatic cases of PD may be medically undiagnosed [22, 23] and some medically known subjects will not be on drug treatment. Although only patients classified as having clinically probable PD were studied, it is probable that up to 20% of this group may have had parkinsonism resulting from a cause other than PD.
The GDS-15 performs well in comparison to formal psychiatric classification of depression, with good sensitivity and reasonable specificity, although the performance of the GDS-15 in the presence of cognitive impairment is less reliable [24] . In this study, patients with marked impairment on the CAMCOG test of cognitive function were excluded. The sensitivity of self-rating scales for depression such as the GDS-15 in medically ill subjects is likely to result in a reasonably large proportion of false-positive results. In our patient group perhaps 30% of the group scoring in the depressed range on the GDS-15 would not be classified as depressed by formal psychiatric diagnosis. Nonetheless, the GDS-15 is still detecting high levels of depressive symptoms in these patients. Since treatment validation studies of the results of screening for depression with instruments such as the GDS-15 in medically ill subjects have not been undertaken, the proportion of our patients with high levels of depressive symptoms who would benefit from antidepressant treatment is unknown. Despite the high levels of depressive symptoms that were detected in this study and evidence of the effectiveness of antidepressant drug treatment in PD [6, 8] , only 7% of patients and 6% of carers were being treated with antidepressants.
Key points
• In a community sample of patients with Parkinson's disease and their carers, marked depressive symptoms detected by self-rated scales were found to be present in two-thirds of patients and one-third of carers.
• Carer distress was predicted by the degree of depressive symptomatology in the patient.
• Despite high levels of depressive symptoms, <10% of subjects in each group were in receipt of antidepressant drug treatment.
